Get started
Author

Meysam Seyedifar

Observed names: M. Seyedifar, M. Seyyedifar, MS Seyedifar/Meysam
ORCID: 0000-0003-0426-1956
Observed ORCID: 0000-0003-0426-1956
OpenAlex ID: A5086646553
Effect of Chromium on Glucose and Lipid Profiles in Patients with Type 2 Diabetes; A Meta-analysis Review of Randomized Trials
2013 · Mohammad Abdollahi, Amir Farshchi, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 71
PDF
Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran.
2016 · Meysam Seyedifar, Farid Abedin Dorkoosh, et al. · PubMed Central · 54
PDF
Consumers’ Willingness to Pay for Pharmacist Counselling Services and the Factors Affecting It in Community Pharmacies
2023 · Omid Soodi, Elahe Hesari, et al. · Iranian journal of pharmaceutical research · 11
PDF
A comparison between on-demand usage of rFVIIa vs prophylaxis use of emicizumab in high titer inhibitory hemophilia A patients in Iran: A cost–utility analysis
2021 · Parisa Saiyarsarai, Atefeh Robabpour Derakhshan, et al. · Medicine · 10
Cost-utility of new film-coated tablet formulation of deferasirox vs deferoxamine among major beta-thalassemia patients in Iran
2020 · Parisa Saiyarsarai, Elahe Khorasani, et al. · Medicine · 7
Cost-Utility Analysis of Erenumab Compared to Topiramate for Preventive Therapy of Migraine in Iran
2024 · Hosein Mollaee, Sadra Nadimi Parashkouhi, et al. · Iranian journal of pharmaceutical research · 3
PDF
Budget impact analysis of temocillin insurance coverage for urinary tract infections caused by ESBL-producing pathogens in Iran
2023 · Meysam Seyedifar, Menhajuddin Sabouri, et al. · Medicine · 2
Cost-Utility Analysis of Trastuzumab-Emtansine Versus Trastuzumab for the Treatment of Residual Invasive HER-2-Positive Breast Cancer in Iran
2024 · Homa Hemati, Marzieh Nosrati, et al. · Iranian journal of pharmaceutical research · 1
PDF
Utilization patterns of cardiovascular medications in patients with diabetes mellitus; a retrospective cross-sectional study, 2013-17
2023 · Negin Hatami, Mohammad-Reza Malekpour, et al. · DARU Journal of Pharmaceutical Sciences · 1
PDF
Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective
2021 · Marzieh Zargaran, Fatemeh Soleymani, et al. · Research in Pharmaceutical Sciences · 1
Economic Evaluation for Benign Prostatic Hyperplasia in Iran: Surgical Treatment or Dutasteride.
2021 · Jamaleddin Khedmati, Fatemeh Soleymani, et al. · PubMed Central · 1
PDF
An evaluation of policies and procedures of successful pharmaceutical exporters and the comparison of Iranian counterpart policy
2015 · Meysam Seyedifar, Shokufeh Nikfar, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Pharmaceutical Utilization Review: A Five-Year Time Trend Analysis of the Pharmaceutical Market in Iran
2026 · Mohammadamir Nemati, Behzad Fatemi, et al. · Iranian journal of pharmaceutical research
PDF
The Relationship Between Quality Assurance Structure and Profitability in Iranian Pharmaceutical Industries
2021 · Abbas Kebriaeezade, Mohammad Sadegh Khoramirad, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Clinical Effectiveness of Ertapenem Versus Piperacillin/Tazobactam in Patients With Mild to Moderate Intraabdominal Infections: A Systematic Review and Metaanalysis of Randomized Controlled Trials
2020 · Mehran Pezeshki, Fatemeh Soleymani, et al. · Avicenna Journal of Clinical Microbiology and Infection
PDF
Pdb25 Cost-effectiveness of Insulin Degludec/aspart Versus Biphasic Insulin Aspart in Patients With Type 2 Diabetes in Iran
2019 · P. Saiyarsarai, A. Ghazizadeh Khosroshahi, et al. · Value in Health
PDF
Psy56 - Cost-utility of New Film-coated Tablet Formulation of Deferasirox Versus Deferoxamine Among Major B-thalassemia Patients in Iran
2018 · E. Khorasani, M. Ghaffari Darab, et al. · Value in Health
PDF
Psy57 - a Comparison Between on Demand Usage of Rfviia Vs Prophylaxis Use of Emicizumab in High Titer Inhibitory Hemophilia a Patients in Iran; a Cost Utility Analysis
2018 · M. Seyedifar, J. Khedmati, et al. · Value in Health
PDF
Cost-Minimization of Availability of Fusidic Acid in the Treatment of Topical Infection in Iran
2018 · Meysam Seyedifar, Elahe Khorasani, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
PDB12 Role of Chromium in Type-2 Diabetes Therapy: A Systematic Review Study
2012 · A. Farshchi, M. Seyedifar, et al. · Value in Health
Php52 an Evaluation of the Policy and the Procedures of Successful Pharmaceutical Exporters and the Comparison Iranian Counterpart Policy
2009 · MS Seyedifar/Meysam · Value in Health
PDF
Works count: 24
Citation count: 163
H-index: 5
I10-index: 4
Year
Topic
Type